Sight Sciences Inc. (NASDAQ:SGHT) on Tuesday announced that UnitedHealthcare has updated its Glaucoma Surgical Treatments policy to cover goniotomy, trabeculotomy, canaloplasty (ab interno), and ...

Sight Sciences, Inc. has announced the launch of the OMNI® Edge Surgical System, an advanced technology designed for minimally invasive glaucoma surgery (MIGS). The new system will be showcased at the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Real-world Omni outcomes showed reductions in IOP and ...

A Meta-Analysis of 22 Studies, and Data from the IRIS® Registry Highlighting Clinical Outcomes in Real-World Clinical Practice, Demonstrates Significant, Long-Term IOP Reduction and Medication ...

MENLO PARK, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Sight Sciences (SGHT), Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A study looked at real-world outcomes with Omni, Hydrus, ...

MENLO PARK, Calif., May 06, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (SGHT) (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative technology that ...

MENLO PARK, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing ...